Rolf Hoffmann, Chief Medical Officer at RepliCel Life Sciences, holds 489.57K shares in RepliCel Life Sciences (Ticker: REPCF). Most recently, Rolf Hoffmann Sold $15,000 shares of RepliCel Life Sciences on Dec 02, 2020 for an estimated value of 2.25K.